Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 1902-1910

  Oue, Naohide ^a   Noguchi, Tsuyoshi ^b   Anami, Katsuhiro ^a   Kitano, Seigo ^b   Sakamoto, Naoya ^a   Sentani, Kazuhiro ^a   Uraoka, Naohiro ^a   Aoyagi, Kazuhiko ^c   Yoshida, Teruhiko ^c   Sasaki, Hiroki ^c   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 7;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROTEIN EXPRESSION;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; KERATIN-7; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865145759     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2175-4     Document Type: Article

References (12)

1. IARC 2003 Oesophageal cancer. In: Stewart BW, Kleihues P (eds) World cancer report. Lyon: IARC Press, pp. 223-7.
2. Goseki N, Koike M, Yoshida M. Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer. 1992;69:1088-93.
3. Courrech Staal EF, van Coevorden F, Cats A, Aleman BM, van Velthuysen ML, Boot H et al. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center. Ann Surg Oncol. 2009;16:3219-26.
4. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer. 2002;94:2874-81. (Pubitemid 34547686)
5. Noguchi T, Oue N, Wada S, Sentani K, Sakamoto N, Kikuchi A et al. h-Prune is an independent prognostic marker for survival in esophageal squamous cell carcinoma. Ann Surg Oncol. 2009;16:1390-6.
6. Isohata N, Aoyagi K, Mabuchi T, Daiko H, Fukaya M, Ohta H et al. Hedgehog and epithelial-mesenchymal transition signaling in normal and malignant epithelial cells of the esophagus. Int J Cancer. 2009;125:1212-21.
7. Sakamoto N, Oue N, Noguchi T, Sentani, K., Anami, K., Sanada, Y, et al. Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esoph-ageal squamous cell carcinoma. Cancer Sci. 2010;101:1038-44.
8. Sano M, Aoyagi K, Takahashi H, Kawamura T, Mabuchi T, Igaki H, et al. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int J Oncol. 2010;36:321-30.
9. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol. 2008;129:705-33.
10. Yamada A, Sasaki H, Aoyagi K, Sano M, Fujii S, Daiko H, et al. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus. Oncol Rep. 2008;20:1021-7.
11. Sobin LH, Wittekind CH, editors. TNM classification of malignant tumors. 6th ed. New York: Wiley-Liss, 2002:60-4.
12. Haleem A, Kfoury H, Al Juboury M, Al Husseini H. Paget's disease of the oesophagus associated with mucous gland carcinoma of the lower oesophagus. Histopathology. 2003;42:61-5. (Pubitemid 36062568)